Curran H V, Gardiner J M, Java R I, Allen D
Institute of Psychiatry, De Crespigny Park, Denmark Hill, London, UK.
Psychopharmacology (Berl). 1993;110(3):374-8. doi: 10.1007/BF02251297.
The effects of lorazepam (2 mg) and placebo upon recognition memory with and without conscious recollection were assessed in a cross-over study with normal volunteers. When recognising a word from study lists presented before and 1, 3 and 5 h after drug administration, subjects were required to indicate whether they could consciously recollect the word's prior occurrence or recognised it on the basis of "knowing"; in the absence of conscious recollection. Lorazepam only impaired word recognition which was accompanied by conscious recollection, and further, the level of this impairment correlated significantly with each of three different indices of subjects' arousal at the time of presentation of each list. Recognition in the absence of conscious recollection was not impaired but somewhat heightened by lorazepam, and these effects did not significantly relate to any index of arousal. These findings are interpreted as providing further support for the notion that recognition entails two distinct components, one based on contextual and associative information and related to conscious recollection, the other possibly based on a "traceless" perceptual or semantic memory system and related to feelings of knowing in the absence of conscious recollection. Implications are drawn for a contextual-encoding/retrieval account of lorazepam-induced amnesia.
在一项针对正常志愿者的交叉研究中,评估了劳拉西泮(2毫克)和安慰剂对有或无意识回忆情况下的识别记忆的影响。当从给药前以及给药后1、3和5小时呈现的学习列表中识别单词时,要求受试者指出他们是能够有意识地回忆起该单词之前出现过,还是基于“知道”而识别它;即在没有意识回忆的情况下。劳拉西泮仅损害了伴有意识回忆的单词识别,而且,这种损害程度与每个列表呈现时受试者觉醒的三个不同指标中的每一个都显著相关。在没有意识回忆的情况下的识别没有受到损害,但劳拉西泮使其有所提高,并且这些效应与任何觉醒指标均无显著关联。这些发现被解释为进一步支持了这样一种观点,即识别需要两个不同的成分,一个基于情境和联想信息且与意识回忆相关,另一个可能基于“无痕迹”的感知或语义记忆系统且与在没有意识回忆时的知道感相关。由此得出了关于劳拉西泮所致失忆的情境编码/检索解释的相关推论。